ArticleThe journal of pathology. Clinical research2015
The prognosis of
Open access · goldAbstract read
In one paragraph
Article in The journal of pathology. Clinical research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 61 citations in OpenAlex.
- Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.The Lancet. Oncology · 2019Trial
- Review
- Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma.iScience · 2025Article
- Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.Blood cancer journal · 2024Article
- Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.Leukemia · 2024Article
- Divergent evolution of metachronous follicular lymphoma and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue from a common precursor.The Journal of pathology · 2023Article
- Genomic landscape of mature B-cell non-Hodgkin lymphomas - an appraisal from lymphomagenesis to drug resistance.Journal of the Egyptian National Cancer Institute · 2022Review
- Decreased CD11c-positive dendritic cells in the tumor microenvironment predict double-hit/triple-hit genotype and survival in diffuse large B-cell lymphoma.The journal of pathology. Clinical research · 2022Article
- Mutational landscape of high-grade B-cell lymphoma withHaematologica · 2022Article
- Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022Article
- Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma.Leukemia · 2022Article
- Primary breast double-hit lymphoma management and outcomes: a real-world multicentre experience.Cancer cell international · 2021Article
- Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents.Molecular cancer research : MCR · 2021Article
- Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications.Therapeutic advances in hematology · 2021Review
- Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020Review
- Article
- Molecular Risk Stratification in Aggressive B-Cell Lymphomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Article
- Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.Virchows Archiv : an international journal of pathology · 2020Review
- Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.Leukemia · 2020Article
- Expression of P63 and its correlation with prognosis in diffuse large B-cell lymphoma: a single center experience.Diagnostic pathology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 10 institutions in 1 country.
Alexandra ClipsonDivision of Molecular Histopathology Department of Pathology University of Cambridge UK.
Sharon BarransHaematological Malignancy Diagnostic Service St. James's Institute of Oncology Leeds UK.
Naiyan ZengDivision of Molecular Histopathology Department of Pathology University of Cambridge UK.
Simon CrouchDepartment of Health Sciences Epidemiology and Cancer Statistics Group University of York York UK.
Nicholas F GrigoropoulosDivision of Molecular HistopathologyDepartment of PathologyUniversity of CambridgeUK; Department of HaematologyAddenbrooke's Hospital, Cambridge University Hospitals NHS Foundation TrustCambridgeUK.
Hongxiang LiuDepartment of Histopathology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
Sylvia KocialkowskiDivision of Molecular Histopathology Department of Pathology University of Cambridge UK.
Ming WangDivision of Molecular Histopathology Department of Pathology University of Cambridge UK.
Yuanxue HuangDivision of Molecular Histopathology Department of Pathology University of Cambridge UK.
Lisa WorrillowHaematological Malignancy Diagnostic Service St. James's Institute of Oncology Leeds UK.
John GoodladDepartment of Pathology Western General Hospital Edinburgh UK.
Jenny BuxtonDepartment of Haematology Western General Hospital Edinburgh UK.
Michael NeatDepartment of Haematology and Department of Cytogenetics GSTS Pathology Guy's and St. Thomas NHS Foundation Trust London UK.
Paul FieldsDepartment of Haematology GSST Kings Health Partners London UK.
Bridget WilkinsHistopathology Department St Thomas' Hospital and King's College London UK.
John W GrantDepartment of Histopathology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
Penny WrightDepartment of Histopathology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
Hesham Ei-DalyDepartment of Haematology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
George A FollowsDepartment of Haematology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
Eve RomanDepartment of Health Sciences Epidemiology and Cancer Statistics Group University of York York UK.
A James WatkinsDepartment of Haematology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust Cambridge UK.
Peter W M JohnsonCancer Research UK Centre University of Southampton Southampton United Kingdom.
Andrew JackHaematological Malignancy Diagnostic Service St. James's Institute of Oncology Leeds UK.
Ming-Qing DuDivision of Molecular HistopathologyDepartment of PathologyUniversity of CambridgeUK; Department of HistopathologyAddenbrooke's Hospital, Cambridge University Hospitals NHS Foundation TrustCambridgeUK.
University of Cambridge · GBAddenbrooke's Hospital · GBSt James's University Hospital · GBCambridge University Hospitals NHS Foundation Trust · GBUniversity of York · GBWestern General Hospital · GBCancer Research UK · GBGuy's and St Thomas' NHS Foundation Trust · GBKings Health Partners · GBSt Thomas' Hospital · GB
Funding
No grant is acknowledged in the PubMed record.
Abstract
A proportion of
Indexed as
chromosome translocationDLBCLdouble‐hitoverall survivalTP53 mutation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.